Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 15 Sep 23 424B3 Prospectus supplement
- 15 Sep 23 EFFECT Notice of effectiveness
- 13 Sep 23 S-4/A Registration of securities issued in business combination transactions (amended)
- 11 Sep 23 S-4/A Registration of securities issued in business combination transactions (amended)
- 25 Aug 23 S-4/A Registration of securities issued in business combination transactions (amended)
-
19 Jul 23 S-4 Registration of securities issued in business combination transactions
TRML similar filings
- 13 Sep 23 Registration of securities issued in business combination transactions (amended)
- 11 Sep 23 Registration of securities issued in business combination transactions (amended)
- 25 Aug 23 Registration of securities issued in business combination transactions (amended)
- 19 Jul 23 Registration of securities issued in business combination transactions
Filing view
External links
Exhibit 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in this Registration Statement on Form S-4 of our report dated March 31, 2023, relating to the consolidated financial statements of Talaris Therapeutics, Inc. appearing in the Annual Report on Form 10-K of Talaris Therapeutics, Inc. for the year ended December 31, 2022. We also consent to the reference to us under the heading “Experts” in such Registration Statement.
/s/ DELOITTE & TOUCHE LLP
Boston, Massachusetts
July 19, 2023